FSD Pharma (OTC: FSDDF) Responds to Therapix Termination of Binding LOI
TORONTO–December 21, 2018-FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) in response to Therapix Biosciences’ termination of the company’s binding letter of intent (LOI) to be acquired by FSD Pharma, […]
